Hina Waheed Chaudhry
Corporate Officer/Principal chez Icahn School of Medicine at Mount Sinai
Profil
Hina Waheed Chaudhry was the founder of VentriNova, Inc. which was founded in 2006 where she held the title of Chief Scientific Officer.
Currently, she is the Director of Cardiovascular Regenerative Medicine at Icahn School of Medicine at Mount Sinai.
Dr. Chaudhry has an undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Postes actifs de Hina Waheed Chaudhry
| Sociétés | Poste | Début |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Anciens postes connus de Hina Waheed Chaudhry
| Sociétés | Poste | Fin |
|---|---|---|
VentriNova, Inc.
 VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Fondateur | - |
Formation de Hina Waheed Chaudhry
| Harvard Medical School | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
VentriNova, Inc.
VentriNova, Inc. Pharmaceuticals: MajorHealth Technology VentriNova, Inc. develops gene therapy for the regeneration of heart tissue in patients with heart failure and after myocardial infarction. The company was founded by Hina Waheed Chaudhry in 2006 and is headquartered in New York, NY. | Health Technology |
